PeptiVir: Universal stabilization

PeptiVir developing flu vaccine using protein stabilization technology

Current peptide stabilization technologies use chemical linkers to keep peptides in their natural state, but in some cases these can cause autoimmune reactions. PeptiVir Inc. aims to avoid such effects by placing hydrophobic amino acids in specific locations within the core of its synthetic peptides to stabilize the compounds.

In the body, peptides are connected to other proteins that act as a stabilizing scaffold to maintain the peptide in a biologically active alpha helix conformation. The alpha helix regions allow the peptides to interact with

Read the full 845 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE